Taking over from the son of the company’s founder at the beginning of 2023, Martin Arès, the CEO of Canadian generics manufacturer Pharmascience, talks to Generics Bulletin about investment, international expansion and biosimilars.
“The ambition is really to double our sales in the next five to six years,” says the CEO of Canadian Rx and OTC generics manufacturer PharmaScience, Martin Arès.
“It took 40 years to reach CAD1bn ($738m) of sales. I would be very disappointed if we don’t reach CAD2bn...
Two experts examine whether melatonin, omega-3, dietary supplements, vitamins, and minerals truly benefit adults with ADHD. While some supplements show promise in supporting brain health, scientific evidence for their effectiveness in improving ADHD symptoms remains limited.
Taking over from the son of the company’s founder at the beginning of 2023, Martin Arès, the CEO of Canadian generics manufacturer Pharmascience, talks to Generics Bulletin about investment, international expansion and biosimilars.
A round-up of the latest global health and wellness moves: Nestlé and Dr Reddy's name JV head; Be-sup hires comms and regulatory director; Ascendis Health appoints interim CFO.
A change in leadership of the US FDA device center is taking place with an eye towards stability in the longer term, but the upcoming elections could lead to more disruptive personnel changes.
David Ball moves from Bayer’s North America business to be Perrigo’s first chief brand and digital officer. He joins CEO who also moved to Perrigo from Bayer with decades of branded product experience.
